Target intelligence / Profile preview

Nucleophosmin pseudogene

Molecular classification
Other (specifically, "Pseudogene")
01

Overview

Nucleophosmin, pseudogene (ENSG00000270449), is a non-functional segment of DNA that resembles the functional nucleophosmin (NPM1) gene but lacks protein-coding capacity due to disabling mutations or processing[5]. Pseudogenes, including those derived from nucleophosmin, do not encode active proteins and are generally the result of gene duplication or retrotransposition events that are subsequently inactivated by deleterious mutations[1][5]. As such, this pseudogene is not a therapeutic target, receptor, or enzyme, and does not possess known biological functions, interact with drugs, or serve as a biomarker. Pseudogenes can sometimes have regulatory roles, but there is no evidence that ENSG00000270449 encodes a functional RNA or regulatory molecule. This entity is not suitable for targeting or therapeutic intervention and its inclusion in a drug target context is likely incorrect[1][5]. Summary of issues: - "Nucleophosmin, pseudogene" is not a protein or receptor, but a pseudogene[5]. - It is not a recognized therapeutic, diagnostic, or functional molecular target. - No standard abbreviation, aliases, biological roles, or disease associations for this pseudogene are established. If you are seeking information about the functional nucleophosmin protein, refer to "Nucleophosmin (NPM1)" instead[2][4][6].

Beyond the preview

Go deeper on Nucleophosmin pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call